Consultancies and service providers at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

7 consultancies and service providers are at TIDES Europe 2026 — 9 presentations on the program. Most represented: Coswald Consulting (1 on the program), Livinovea (1 on the program), LuminaBio Advisory (1 on the program). 2 of them have their own page in this guide. As of Sep 25, 2026.

All 160 organizations at TIDES Europe 2026 →

Showing 1–7 of 7 organizations

Organization	TIDES Europe 2026 Attendance
CC Coswald Consulting
	Talk Tue Nov 3 11:25–12:00 Drug Substance and Drug Product Examples and Applications Workshop #2:Oligonucleotide CMC Across the Product Lifecycle: From Preclinical to Market Keynote Tue Nov 3 09:00–09:10 Moderator’s Welcome and Opening Remarks Why manufacturing and quality planning for oligonucleotide drugs should start early and span test methods, chemistry choices and raw-material supply.
Livinovea
livinovea.com Consulting & services Swiss consultancy providing business, operational and technical support, including tech transfer and process optimization, to pharma, biotech and CDMOs.	Talk Tue Nov 3 09:00–12:00 CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact Which early manufacturing and quality decisions set what an oligonucleotide drug costs to produce, and when in development they should be taken. with Axolabs Talk Thu Nov 5 08:00–08:05 Chairwoman's Remarks: Innovations in Oligonucleotide CMC Oligonucleotide Chemistry, Manufacturing & Controls
LuminaBio Advisory
luminabioadvisory.com Consulting & services Life sciences consultancy advising biotech and pharmaceutical companies on CMC and regulatory strategy.	Talk Tue Nov 3 09:45–10:20 Future-Proofing Oligonucleotide Manufacturing: Starting-Material Strategy for Scale-Up, Platform Change, and Commercial Supply Continuity Why the choice and control of starting materials decides whether oligonucleotide manufacturing survives scale-up, a platform switch or a site transfer.
MW Mike Webb Pharma
Consulting & services Consultancy advising on oligonucleotide CMC development, analysis and manufacture from preclinical work to marketing submission.	Talk Thu Nov 5 13:55–14:00 Chairman's Remarks: Delivery, Analytical and CMC Strategies for Oligonucleotides Oligonucleotide Chemistry, Manufacturing & Controls
MC ML Consult
	Talk Tue Nov 3 09:10–09:45 Drug Substance and Drug Product and How CMC Early in the Discovery Lifecycle Can Help Why a careful handover from making the drug substance to making the finished product makes the paperwork for first clinical trials easier.
R Rasayan
Consulting & services Consultancy advising on oligonucleotide manufacturing and sourcing nucleic acid raw materials for drug and diagnostics developers.	Talk Wed Nov 4 13:55–14:00 Chairman’s Remarks: Emerging Technologies in Oligonucleotide Manufacturing Oligonucleotide Chemistry, Manufacturing & Controls
SB Sinawali Biotechnology Solutions
	Talk Tue Nov 3 10:50–11:25 Bioanalytical and Analytical Approaches and Alignment A review of the now-standard laboratory tests for oligonucleotide drugs, and what changes for mRNA and for oligonucleotides attached to antibodies.